- Cognyte Software reported fourth-quarter 2026 results showing revenue of US$106.24 million and net income of US$3.76 million, alongside full-year revenue of US$400.04 million and a sharply reduced annual net loss, while also updating on its share buyback and filing an ESOP-related shelf registration for 3,300,000 ordinary shares worth US$26.00 million.
- The company also announced a US$5 million tactical SIGINT contract win with a major U.S. state law enforcement agency and issued guidance targeting double-digit revenue growth with faster profit improvement in fiscal 2027, highlighting a combination of operational progress and expanding public-sector relationships.
- We’ll now examine how Cognyte’s improved profitability and upbeat revenue guidance shape its investment narrative for investors assessing its longer-term potential.
Uncover the next big thing with 33 elite penny stocks that balance risk and reward.
What Is Cognyte Software's Investment Narrative?
To own Cognyte today, you really have to believe the company can turn its improving operating profile into durable profitability in a niche but sensitive part of the software market. The latest quarter edges that story forward: revenue is higher, losses have nearly disappeared, and management is now openly targeting double‑digit growth with faster profit improvement in fiscal 2027. The US$5 million US law‑enforcement SIGINT win and prior EMEA/APAC deals reinforce the idea that Cognyte’s “land‑and‑expand” model with security agencies may still have room to run, even if this single contract is not transformative on its own. At the same time, the ESOP share registration slightly dilutes the signal from the ongoing buyback, and leaves execution risk squarely in focus for a stock that has lagged the wider market over the past year.
However, there is one execution risk here that investors should not overlook. Cognyte Software's shares have been on the rise but are still potentially undervalued by 44%. Find out what it's worth.Exploring Other Perspectives
Explore 3 other fair value estimates on Cognyte Software - why the stock might be a potential multi-bagger!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Cognyte Software research is our analysis highlighting 4 key rewards that could impact your investment decision.
- Our free Cognyte Software research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cognyte Software's overall financial health at a glance.
No Opportunity In Cognyte Software?
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
- The latest GPUs need a type of rare earth metal called Dysprosium and there are only 26 companies in the world exploring or producing it. Find the list for free.
- Find 58 companies with promising cash flow potential yet trading below their fair value.
- We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com